S12 NONCLINICAL BIODISTRIBUTION CONSIDERATIONS FOR GENE THERAPY PRODUCTS: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 1, 2023
May 2, 2023
f0e813d3-46bd-49f2-846f-f5f95f9d4892
Related Documents
Benefit-Risk Assessment for New Drug and Biological Products
Guidance DocumentOctober 17, 2023Center for Drug Evaluation and Research
Development of Anti-Infective Drug Products for the Pediatric Population : Guidance for Industry
Guidance DocumentDecember 9, 2021Center for Drug Evaluation and Research
Rare Diseases: Considerations for the Development of Drugs and Biological Products
Guidance DocumentDecember 26, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.